David Wang

26.5k total citations · 8 hit papers
227 papers, 15.6k citations indexed

About

David Wang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, David Wang has authored 227 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Epidemiology, 49 papers in Pulmonary and Respiratory Medicine and 39 papers in Neurology. Recurrent topics in David Wang's work include Acute Ischemic Stroke Management (60 papers), Cerebrovascular and Carotid Artery Diseases (23 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). David Wang is often cited by papers focused on Acute Ischemic Stroke Management (60 papers), Cerebrovascular and Carotid Artery Diseases (23 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). David Wang collaborates with scholars based in United States, China and Taiwan. David Wang's co-authors include Bo Hu, Yanan Li, Huijuan Jin, Yifan Zhou, Ling Mao, Mengdie Wang, Jiang Chang, Yongjun Wang, Candong Hong and Quanwei He and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of the American Chemical Society.

In The Last Decade

David Wang

217 papers receiving 15.2k citations

Hit Papers

Neurologic... 1985 2026 1998 2012 2020 2017 2013 1985 2020 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wang United States 44 6.0k 4.6k 3.9k 2.3k 2.2k 227 15.6k
Daniel F. McAuley United Kingdom 65 3.7k 0.6× 4.8k 1.1× 5.9k 1.5× 9.5k 4.1× 1.6k 0.7× 371 24.6k
Julien Labreuche France 54 3.2k 0.5× 7.3k 1.6× 1.1k 0.3× 4.7k 2.0× 2.7k 1.2× 339 13.3k
You Shang China 37 3.2k 0.5× 1.3k 0.3× 5.6k 1.4× 1.7k 0.7× 320 0.1× 165 11.4k
Xiaoping Miao China 54 4.3k 0.7× 1.0k 0.2× 3.2k 0.8× 1.3k 0.5× 381 0.2× 313 15.3k
Mitchell S.V. Elkind United States 86 4.5k 0.8× 10.4k 2.3× 798 0.2× 6.5k 2.8× 10.5k 4.8× 620 30.7k
Alejandro A. Rabinstein United States 76 13.2k 2.2× 9.8k 2.1× 663 0.2× 6.3k 2.7× 4.7k 2.1× 701 29.8k
Shiying Yuan China 34 2.8k 0.5× 1.1k 0.2× 5.0k 1.3× 1.4k 0.6× 248 0.1× 85 9.3k
Pierre‐Marie Preux France 54 2.7k 0.5× 1.1k 0.3× 1.2k 0.3× 1.1k 0.5× 787 0.4× 512 13.3k
Vicki Hertzberg United States 48 4.3k 0.7× 6.5k 1.4× 324 0.1× 5.2k 2.2× 2.6k 1.2× 181 15.2k
Tobias Kurth United States 78 2.4k 0.4× 2.9k 0.6× 240 0.1× 3.0k 1.3× 2.8k 1.3× 350 20.3k

Countries citing papers authored by David Wang

Since Specialization
Citations

This map shows the geographic impact of David Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wang more than expected).

Fields of papers citing papers by David Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wang. The network helps show where David Wang may publish in the future.

Co-authorship network of co-authors of David Wang

This figure shows the co-authorship network connecting the top 25 collaborators of David Wang. A scholar is included among the top collaborators of David Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wang. David Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cummings, Jeffrey L., Pedro Such, David Wang, et al.. (2025). Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer’s disease. Current Medical Research and Opinion. 41(8). 1523–1534. 1 indexed citations
2.
Yu, Zhihai, et al.. (2025). Market competition, environmental, social and corporate governance investment, and enterprise green innovation performance. Finance research letters. 77. 107057–107057. 8 indexed citations
3.
Phillips, Tiffany R., Eric P. F. Chow, Christopher K. Fairley, et al.. (2025). Using Online Media to Increase the Awareness and Uptake of Preexposure Prophylaxis for HIV Among Asian-Born Men Who Have Sex With Men Living in Australia: An Open-Label Randomized Controlled Trial. Open Forum Infectious Diseases. 12(7). ofaf321–ofaf321.
4.
Liu, Liping, Zixiao Li, Hongyu Zhou, et al.. (2023). Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update. Stroke and Vascular Neurology. 8(6). e3–e3. 51 indexed citations
5.
Meng, Rui, Junjie Jiang, Yan Luo, et al.. (2023). Association of white matter hyperintensities with long‐term EGFR‐TKI treatment and prediction of progression risk. Brain and Behavior. 13(12). e3326–e3326. 2 indexed citations
6.
Looney, Austin M., et al.. (2022). Operative vs. nonoperative treatment of distal biceps ruptures: a systematic review and meta-analysis. Journal of Shoulder and Elbow Surgery. 31(4). e169–e189. 8 indexed citations
7.
Mane, Ravikiran, Zhenhua Wu, & David Wang. (2022). Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review. Stroke and Vascular Neurology. 7(6). 541–549. 36 indexed citations
8.
Li, Yanan, Hong‐Wen Liang, Chunlin Zhang, et al.. (2022). Ophthalmic Solution of Smart Supramolecular Peptides to Capture Semaphorin 4D against Diabetic Retinopathy. Advanced Science. 10(3). e2203351–e2203351. 18 indexed citations
9.
Schwartz, Rachel, et al.. (2021). Harnessing the Chaplain’s Capacity to Identify Unmet Palliative Needs of Vulnerable Older Adults in the Emergency Department. Journal of Palliative Care. 37(4). 480–485. 3 indexed citations
10.
Schreglmann, Sebastian R., David Wang, Robert L. Peach, et al.. (2021). Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence. Nature Communications. 12(1). 363–363. 70 indexed citations
11.
Pan, Yuesong, Runqi Wangqin, Hao Li, et al.. (2020). F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA. Neurology. 96(1). e1–e9. 6 indexed citations
12.
Wang, Yongjun, Zixiao Li, Hongqiu Gu, et al.. (2020). China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke and Vascular Neurology. 5(3). 211–239. 334 indexed citations breakdown →
13.
Wang, Yongjun, S. Claiborne Johnston, Philip M. Bath, et al.. (2019). Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack. BMJ. 364. l895–l895. 25 indexed citations
14.
Nunes, Marta C., Adriana Weinberg, Clare Cutland, et al.. (2018). Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women. PLoS ONE. 13(12). e0210124–e0210124. 13 indexed citations
15.
Lin, Yi, Anxin Wang, Jiejie Li, et al.. (2017). Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants. Stroke. 48(4). 998–1004. 9 indexed citations
16.
Wang, David, et al.. (2017). Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair. Case Reports in Anesthesiology. 2017. 1–4.
17.
Wang, David, Li Gui, Yi Dong, et al.. (2016). Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial. Stroke and Vascular Neurology. 1(2). 29–36. 26 indexed citations
18.
Wang, Yilong, Yuesong Pan, Xingquan Zhao, et al.. (2015). Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial. Circulation. 132(1). 40–46. 158 indexed citations
19.
Wang, Yilong, Yuesong Pan, Xingquan Zhao, et al.. (2014). Recurrent Stroke was Associated with Poor Quality of Life in Patients with Transient Ischemic Attack or Minor Stroke: Finding from the CHANCE Trial. CNS Neuroscience & Therapeutics. 20(12). 1029–1035. 53 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026